文献速递慢性肾脏病肾血管病与高血压

THOC5依赖的转录后调控维持血管平滑肌细胞稳态对抗CKD相关血管钙化

The osteogenic regulator THOC5-dependent post-transcriptional control maintains vascular smooth muscle cell homeostasis against chronic kidney disease-related vascular calcification.
PubMed 文献 · Kidney Int · 2026-09-24

本研究探讨THOC5在慢性肾脏病(CKD)相关血管钙化中对血管平滑肌细胞(VSMC)转录后调控的作用。发现THOC5在钙化动脉中表达上调,其缺失加重钙化而过表达减轻钙化。机制上THOC5通过促进GEF mRNA核输出和稳定性维持RhoA活性,从而抑制VSMC成骨转分化。

要点

  • THOC5在CKD患者和小鼠钙化动脉中表达上调,发挥代偿性保护作用。
  • THOC5通过GEF-RhoA轴维持VSMC收缩表型,抑制成骨转分化。
  • THOC5过表达可恢复GEF mRNA转运并减轻血管钙化。

核心结论

  • THOC5-GEF-RhoA轴转录后调控VSMC表型稳定性,THOC5过表达可减轻CKD相关血管钙化。

研究设计与样本

  • 采用CKD患者和小鼠动脉组织检测钙化与THOC5表达,结合体内外VSMC钙化模型评估THOC5功能。
  • 运用RIP-Seq、RNA-FISH和EMSA解析THOC5调控机制。

主要发现

  • THOC5在钙化动脉中表达上调,THOC5缺失加重VSMC钙化,过表达减轻钙化。
  • THOC5选择性结合GEF mRNA促进其核输出和稳定性,维持RhoA GTPase活性。
  • 促钙化条件下THOC5与GEF mRNA结合减少,RhoA活性下降,收缩标志物表达降低。
  • RhoA抑制剂Y27632逆转THOC5的保护作用。

临床怎么用

  • THOC5过表达可能作为减轻CKD相关血管钙化的潜在策略,但需进一步临床验证。

局限性

  • 研究主要基于动物模型和体外实验,人体证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs) plays a fundamental role in chronic kidney disease (CKD)-associated vascular calcification (VC). Despite its significance, the post-transcriptional control mechanisms driving VSMC osteogenic switching remain poorly understood. Here, we sought to elucidate the THOC5-dependent post-transcriptional regulatory mechanisms that control VSMC transdifferentiation and contribute to CKD-associated VC. METHODS: von Kossa staining and immunohistochemistry were used to detect calcification and THOC5 expression in arterial tissues from patients with CKD and mice. In vitro and in vivo models of VSMC calcification were used to assess the effects of THOC5. RNA immunoprecipitation sequencing (RIP-Seq), RNA fluorescence in situ hybridization (RNA-FISH), and electrophoretic mobility shift assays (EMSA) were employed to elucidate the underlying regulatory mechanisms. RESULTS: THOC5 expression was upregulated in calcified arteries from patients with CKD and mouse models. Functionally, THOC5 deficiency exacerbated VSMC calcification, while THOC5 overexpression mitigated calcification both in vitro and in vivo. Mechanistically, THOC5 selectively associated with guanine nucleotide exchange factor (GEF) mRNAs and facilitated their nuclear export and maintained their transcript stability, thereby sustaining RhoA GTPase activity. Under procalcifying conditions, this engagement was diminished, resulting in reduced RhoA activity and decreased expression of VSMC contractile markers. Pharmacological inhibition of RhoA signaling (Y27632) reversed the protective effects of THOC5. Notably, THOC5 overexpression restored GEF mRNA transport and suppressed osteogenic transition. CONCLUSIONS: Our study identifies a THOC5-GEF-RhoA regulatory axis that post-transcriptionally governs VSMC phenotypic stability during CKD-associated VC. Endogenous THOC5 upregulation in calcified vasculature likely represents a compensatory but insufficient response, as osteogenic stress impairs the formation of functional THOC5-containing export complexes. THOC5 overexpression restores this process and attenuates VC.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Cheng A, Wang Y, Liu Y, et al. The osteogenic regulator THOC5-dependent post-transcriptional control maintains vascular smooth muscle cell homeostasis against chronic kidney disease-related vascular calcification. Kidney Int. 2026. PMID: 42778145. doi:10.1016/j.kint.2026.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。